Kazia Therapeutics Limited
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 57.21 | -100% | -5.19 | -100% |
| P/S |
|
61225.34 | 33.44 | 183013.65% |
|
|
| P/BV |
|
2.82 | 4.65 | -39.33% |
|
|
| P/FCF |
|
0 | 39.66 | -100% |
|
|
| Ev/Ebitda |
|
-1.37 | -17.68 | -92.25% |
|
|
| Ev/S |
|
13.23 | 22.52 | -41.26% |
|
|
| Ev/FCF |
|
-3.19 | 47.58 | -106.7% |
|
|
| E/P |
|
0 | 0.0172 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-1159.71 | -14.58 | 7852.25% | -20597909.41 | -99.99% |
| ROE |
|
-2633.62 | 9.48 | -27874.21% |
|
|
| ROA |
|
-107.82 | 0.1068 | -101060.54% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-1160.23 | -26.35 | 4302.58% |
|
|
| ROCE |
|
285.86 | 14.58 | 1861.3% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0237 | -3.62 | -99.35% | -0.0575 | -58.81% |
| Nеt Debt/Ebitda |
|
0.0382 | -4.05 | -100.94% |
|
|
| Debt/Ratio |
|
0.0294 | 0.1841 | -84.05% |
|
|
| Debt/Equity |
|
0 | 1.6 | -100% |
|
|
| Debt/Net Income |
|
-0.0237 | 0.9168 | -102.58% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5448 | -100% | 71.67 | -100% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0.5 | 0.2387 | 109.45% |
|
|
| Average dividend growth |
|
-23.93 | 1.55 | -1645.81% |
|
|
| Average percentage for 5 years |
|
71.67 | 0.4954 | 14366.81% |
|
|
| Average percentage for payments |
|
0 | 43.69 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5448 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
217430.63 | 31.71 | 685584.74% | ||
| Growth impulse Ebitda in 5 years |
|
133.95 | -23.28 | -675.39% | ||
| Growth impulse Net Income in 5 years |
|
114.79 | -61.56 | -286.47% | ||
| Growth impulse FCF in 5 years |
|
8.75 | -8.35 | -204.79% | ||
| Growth impulse EPS in 5 years |
|
835.57 | -64.95 | -1386.48% |
IP Score
5.32/10
